Matulionė, J. 2023. ADJUVANT ATEZOLIZUMAB AFTER RADICAL RESECTION AND ADJUVANT CHEMOTHERAPY IN STAGE IB–IIIA NON-SMALL-CELL LUNG CANCER. IMPOWER010 CLINICAL TRIAL. Pulmonology and allergology. 7, 2 (Aug. 2023), 189-195. DOI:https://doi.org/10.37499/PIA.1243.